Search result for UGT1A1
Moderna and ILCM to collaborate in order to develop a new mRNA therapeutic for Crigler-Najjar Syndrome Type 1 (CN-1)
Highlights
- Both the companies are collaborating to develop mRNA-3351
- CN-1is a rare disease caused due to mutation in gene UGT1A1
The Institute for Life Changing Medicines (ILCM) and the Moderna have announced their collab...